NL-OMON36614已完成2 期
Randomised open label cross-over study into the efficacy of RApamycin in children with Tuberous sclerosis complex with intractable Epilepsy - RATE-trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 11（—）
入选标准
- •Children with definite TSC older than 3 months, up to 12 yrs old, with catastrophic epilepsy (West syndrome or intractable epilepsy defined as 1 or more seizures/week despite two adequate trials of anti-epileptic drug regimens).
排除标准
- •Renal dysfunction, surgery during 6wk before inclusion, current infection.
研究者
相似试验
进行中（未招募）
不适用
Randomised open label cross-over study into the efficacy of RApamycin in children with Tuberous sclerosis complex with intractable Epilepsy (RATE-trial) - RATEEUCTR2010-022655-29-NLErasmus MC
已完成
不适用
Study into treatment of children with difficult to treat epilepsy due to Tuberous sclerosis complex with Rapamycin.TSCTuberous sclerosis complexTubereuze sclerose complexRapamycinRapamycineEpilepsyEpilepsiemTORmTORC1NL-OMON28870Erasmus University Medical Center23
进行中（未招募）
1 期
A Study of Xenical (Orlistat) in Overweight and Obese AdolescentsEUCTR2016-001661-91-Outside-EU/EEAF. Hoffmann-La Roche AG80
尚未招募
2 期
Kushtadi churna and pippalyadi churna pratisarana in tundikeri vis-a-vis chronic tonsillitisCTRI/2024/05/067358Dr MD Shahid Musaib
尚未招募
4 期
Role of Melbild Solution in the treatment of VitiligoCTRI/2017/06/008845Alkem Laboratories Limited120